Nature Outlook |

The Spinoff Prize 2021

The path from university research to start-up company is an essential part of the innovation economy. This Outlook presents some star spin-offs that took root after seeds of scientific insight fell on fertile commercial soil.

This Nature Outlook is editorially independent, produced with financial support from a third party. About this content.


Start-up companies spawned at universities are transforming research findings into commercial offerings for biomedicine and technology.

Outlook | | Nature

Start-up company HighT-Tech has developed a technique to make alloys that could improve catalysts or be used to build better batteries. The company is the winner of The Spinoff Prize 2021.

Outlook | | Nature

Here are ten university spin-offs that just missed making the final eight in the 2021 Spinoff Prize competition, but are worth keeping an eye on.

Outlook | | Nature

More from Nature Portfolio

Our annual survey highlights startups tackling intractable viruses with new vaccine design, engineering a reliable source of platelets, universalizing cell therapies, improving cancer screening, developing RNA-editing platforms and targeting protein–RNA interactions. Michael Eisenstein, Ken Garber, Caroline Seydel and Laura DeFrancesco report.

Feature | | Nature Biotechnology

A detailed look at the economic impact of university-licensed life science startups across the United States reveals vast differences in the effectiveness of different regions to create ventures and sustain them as viable entities.

Building a Business | | Nature Biotechnology